DNA Synthesis Reagents and Columns
Medchemexpress LLC 5'-O-DMT-3'-O-TBDMS-Ac-rC | 123956-65-0 | 99.2% | 701.88 | 1 ML
5'-O-DMT-3'-O-TBDMS-Ac-rC is a modified nucleoside that can be utilized for synthesizing DNA or RNA.
- Modified nucleoside for DNA or RNA synthesis.
- Appearance: solid, white to off-white.
- Storage conditions: 4°C, protected from light; in solvent, -80°C for 6 months; -20°C for 1 month (protect from light).
- Solubility: 100 mg/mL in DMSO.
Medchemexpress LLC DMT-2'Fluoro-DG(IB) Amidite | 144089-97-4 | 99.5% | C44H53FN7O8P | 1 ML
DMT-2'Fluoro-DG(IB) Amidite is a nucleoside that can be employed for oligonucleotide synthesis. It can be used to prepare 4'-modified 2'-deoxy-2'-fluorouridine. It is a modified nucleoside phosphoramidite with a fluorine on the 2' position.
- Employed for oligonucleotide synthesis
- Used to prepare 4'-modified 2'-deoxy-2'-fluorouridine
- Modified nucleoside phosphoramidite with a fluorine on the 2' position
- Related to oligonucleotides, phosphoramidites, and guanine
- Relevant to cancer, blood or cardio-cerebrovascular disease, blood disease, lung cancer, leukemia/lymphoma/myeloma, cancer metabolism and metastasis
- Acts as a nucleoside antimetabolite/analog
- Functions as an inhibitor
CAMBRIDGE ISOTOPE LABORATORIES TCA CYCLE STANDARD MIX SETS 1
NC2667200 TCA CYCLE STANDARD MIX SETS 1
Biotage GLUTATHIONE PHYTIP COL 300 UL
Glutathione PhyTip® columns (300 µL volume) containing 20 µL affinity media per column, DD/Biotix 96pk
Abcam YC-1, guanylyl cyclase activator, 10MG
MW 304.3 Da, Purity >99%. Reversible soluble guanylyl cyclase activator (EC₅₀ = 18.6 μM). NO-independent. Induces a concentration dependent increase in cGMP in vitro. Reduces blood-brain barrier permeability through HIF-1 inhibiton in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Abcam YC-1, guanylyl cyclase activator, 50MG
MW 304.3 Da, Purity >99%. Reversible soluble guanylyl cyclase activator (EC₅₀ = 18.6 μM). NO-independent. Induces a concentration dependent increase in cGMP in vitro. Reduces blood-brain barrier permeability through HIF-1 inhibiton in vivo.
The product is subject to the following: Abcam Restricted Use Statement